Eli Lilly and Company v. Eagle Pharmaceuticals, Inc.
1:17-cv-01293
Overview
Parties
Defendant
Eagle Pharmaceuticals, Inc. Operating Company
Represented By
8 Attorneys ListedGreenberg Traurig LLP
1007 North Orange Street, Suite 1200
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Plaintiff
Eli Lilly and Company Operating Company
Represented By
10 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,772,209 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2010021058 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 21,531,000 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 23,585,900 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 28,444,801 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,053,065 B2 | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2002002093 A2 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 2006007948 | US Continuation / Sibling | View Official Patent → |
Apotex Inc. et al. v. Eli Lilly and Company
Wockhardt Bio AG et al. v. Eli Lilly and Company
Apotex Inc. et al. v. Eli Lilly and Company
Teva Pharmaceuticals USA, Inc. et al. v. Eli Lilly and Company
Apotex Inc. et al. v. Eli Lilly and Company
Teva Pharmaceuticals USA, Inc. et al. v. Eli Lilly and Company
Teva Pharmaceuticals USA, Inc. et al. v. Eli Lilly and Company
Wockhardt Bio AG et al. v. Eli Lilly and Company
Wockhardt Bio AG et al. v. Eli Lilly and Company
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7772209
Antifolate combination therapies
|
Filed: 2007-07-11
Issued: 2010-08-10
|
Expired (Term Ended)
Expires: 2021-11-24
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
51
Dispositive
2
Granted
0
Denied
1
Pending / Review
46
Motions by Category
Key Dispositive Motions & Rulings